Determination of the Prevalence of Microsatellite Instability, BRAF and KRAS/NRAS Mutation Status in Patients with Colorectal Cancer in Slovakia

被引：0
|
作者：
Rendek, Tomas [1 ]
Saade, Rami [2 ]
Pos, Ondrej [3 ,4 ]
Kolnikova, Georgina [5 ]
Urbanova, Monika [5 ]
Budis, Jaroslav [3 ,4 ]
Mihok, Luboslav [6 ]
Tomas, Miroslav [7 ]
Szemes, Tomas [3 ,4 ]
Repiska, Vanda [1 ]
机构：
[1] Comenius Univ, Inst Med Biol Genet & Clin Genet, Fac Med, Bratislava 81108, Slovakia
[2] Comenius Univ, Fac Med, Dept Gynaecol & Obstet 2, Bratislava 81108, Slovakia
[3] Geneton Ltd, Bratislava 84104, Slovakia
[4] Comenius Univ, Sci Pk, Bratislava 84104, Slovakia
[5] NCI, Dept Pathol Anat, Bratislava 83310, Slovakia
[6] NCI, Dept Med Genet, Bratislava 83310, Slovakia
[7] Slovak Med Univ, NCI, Surg Oncol Clin, Bratislava 83310, Slovakia
来源：
CANCERS | 2024年 / 16卷 / 06期
关键词：
microsatellite instability; colorectal cancer; BRAF; KRAS; NRAS mutations; RAS MUTATIONS; KRAS; BENEFIT;
D O I：
10.3390/cancers16061128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Slovakia has one of the highest rates of colorectal cancer among the developed countries, ranking as the second highest in the incidence of this disease for men worldwide. Despite the significant burden on both quality of life and the healthcare system this disease imposes, data on molecular analysis of biomarkers in CRC-diagnosed patients is scarce. In our study, we analyzed confirmed CRC patients from the database of the National Cancer Institute (NCI) and evaluated the presence of 4 biomarkers in tumor tissues. Altogether, 83 FFPE tumor tissues from CRC patients listed in the NCI database were analyzed for microsatellite instability status, presence of BRAF and KRAS/NRAS mutations, and neoplastic cell percentage in tissue samples. We identified 4 MSI-high samples, 39 KRAS/NRAS mutations, and 5 BRAF p.V600E mutations, with one case of coexistence of all three markers in a single tumor sample. We also evaluated possible relationships between biomarkers, their coexistence, and the age and sex of the studied population.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
    Jonas Cicenas
    Linas Tamosaitis
    Kotryna Kvederaviciute
    Ricardas Tarvydas
    Gintare Staniute
    Karthik Kalyan
    Edita Meskinyte-Kausiliene
    Vaidotas Stankevicius
    Mindaugas Valius
    Medical Oncology, 2017, 34
  • [22] Liquid biopsy for KRAS, NRAS and BRAF mutation testing in advanced colorectal cancer patients: the Argentinean experience
    Guettlein, Leandro
    Luca, Maria R.
    Esteso, Federico
    Fresno, Cristobal
    Mariani, Javier
    Pizarro, Mercedes Otero
    Brest, Esteban
    Starapoli, Solange
    Kreimberg, Kevin
    Teves, Paula
    Bertelli, Andrea Mendoza
    Girotti, Maria R.
    Salanova, Ruben
    O'Connor, Juan M.
    FUTURE ONCOLOGY, 2022, 18 (29) : 3277 - 3287
  • [23] Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia
    Li, Yang
    Xiao, Jun
    Zhang, Tiancheng
    Zheng, Yanying
    Jin, Hailin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer
    Vaughn, Cecily P.
    ZoBell, Scott D.
    Furtado, Larissa V.
    Baker, Christine L.
    Samowitz, Wade S.
    GENES CHROMOSOMES & CANCER, 2011, 50 (05): : 307 - 312
  • [25] Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
    Yang, Qiwei
    Huo, Sibo
    Sui, Yujie
    Du, Zhenwu
    Zhao, Haiyue
    Liu, Yu
    Li, Wei
    Wan, Xin
    Liu, Tongjun
    Zhang, Guizhen
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [26] Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer
    Gutierrez, Martin E.
    Price, Kristin S.
    Lanman, Richard B.
    Nagy, Rebecca J.
    Shah, Irfan
    Mathura, Shivam
    Mulcahy, Michael
    Norden, Andrew D.
    Goldberg, Stuart L.
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 9
  • [27] Evaluating the Combination of Microsatellite Instability and Mutation in BRAF as Prognostic Factors for Patients With Colorectal Cancer
    Sinicrope, Frank A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 391 - 394
  • [28] KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients
    El Zaitouni, Sara
    Laraqui, Abdelilah
    Ghaouti, Meriem
    Benzekri, Asmae
    Kettani, Fouad
    Bajjou, Tahar
    Sekhsokh, Yassine
    Benmokhtar, Soukaina
    Jafari, Meryem
    Baba, Walid
    Oukabli, Mohamed
    El Annaz, Hicham
    Abi, Rachid
    Tagajdid, Mohamed Rida
    El Kochri, Safae
    Lahlou, Idriss Amine
    El Hassani, Rabii Ameziane
    Ennibi, Khalid
    CANCER CONTROL, 2024, 31
  • [29] First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients
    Moiseyenko, Vladimir M.
    Moiseyenko, Fedor, V
    Yanus, Grigoriy A.
    Kuligina, Ekatherina Sh
    Sokolenko, Anna P.
    Bizin, Ilya, V
    Kudriavtsev, Alexey A.
    Aleksakhina, Svetlana N.
    Volkov, Nikita M.
    Chubenko, Vyacheslav A.
    Kozyreva, Kseniya S.
    Kramchaninov, Mikhail M.
    Zhuravlev, Alexandr S.
    Shelekhova, Kseniya, V
    Pashkov, Denis, V
    Ivantsov, Alexandr O.
    Venina, Aigul R.
    Sokolova, Tatyana N.
    Preobrazhenskaya, Elena, V
    Mitiushkina, Natalia, V
    Togo, Alexandr, V
    Iyevleva, Aglaya G.
    Imyanitov, Evgeny N.
    CLINICAL DRUG INVESTIGATION, 2018, 38 (06) : 553 - 562
  • [30] Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
    Yang, Yingchi
    Wang, Dong
    Jin, Lan
    Wu, Guocong
    Bai, Zhigang
    Wang, Jin
    Yao, Hongwei
    Zhang, Zhongtao
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3911 - 3929
12345